Suneetha B. Thomas

1.3k total citations
17 papers, 1.0k citations indexed

About

Suneetha B. Thomas is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suneetha B. Thomas has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suneetha B. Thomas's work include Epigenetics and DNA Methylation (5 papers), Cancer Cells and Metastasis (4 papers) and Prostate Cancer Treatment and Research (3 papers). Suneetha B. Thomas is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer Cells and Metastasis (4 papers) and Prostate Cancer Treatment and Research (3 papers). Suneetha B. Thomas collaborates with scholars based in United States, Uruguay and Australia. Suneetha B. Thomas's co-authors include William L. Farrar, Elaine M. Hurt, George J. Klarmann, Brian T. Kawasaki, Benjamin Peng, Marı́a Ana Duhagon, Maria A. Serrat, Lesley Mathews, Xiaohu Zhang and David R. Hodge and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Suneetha B. Thomas

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suneetha B. Thomas United States 12 628 522 256 242 95 17 1.0k
Georgia Konstantinidou Switzerland 18 920 1.5× 374 0.7× 450 1.8× 204 0.8× 94 1.0× 26 1.3k
Babita Saigal United States 15 723 1.2× 460 0.9× 175 0.7× 288 1.2× 87 0.9× 26 1.2k
Yu-Mei Feng China 21 847 1.3× 466 0.9× 383 1.5× 146 0.6× 92 1.0× 41 1.3k
Puspa R. Pandey United States 13 908 1.4× 617 1.2× 473 1.8× 285 1.2× 168 1.8× 24 1.5k
Rumey C. Ishizawar United States 8 600 1.0× 436 0.8× 111 0.4× 170 0.7× 134 1.4× 13 1.1k
Filippo Petti United States 7 829 1.3× 789 1.5× 298 1.2× 437 1.8× 112 1.2× 8 1.4k
Richard J. Salamone United States 5 500 0.8× 431 0.8× 189 0.7× 191 0.8× 92 1.0× 5 798
Alexandra Eyzaguirre United States 8 722 1.1× 564 1.1× 263 1.0× 244 1.0× 46 0.5× 13 1.1k
Tim P. Green United Kingdom 13 699 1.1× 504 1.0× 133 0.5× 159 0.7× 95 1.0× 14 1.2k
Wells S. Brown United States 15 552 0.9× 266 0.5× 206 0.8× 139 0.6× 64 0.7× 24 895

Countries citing papers authored by Suneetha B. Thomas

Since Specialization
Citations

This map shows the geographic impact of Suneetha B. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suneetha B. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suneetha B. Thomas more than expected).

Fields of papers citing papers by Suneetha B. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suneetha B. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suneetha B. Thomas. The network helps show where Suneetha B. Thomas may publish in the future.

Co-authorship network of co-authors of Suneetha B. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Suneetha B. Thomas. A scholar is included among the top collaborators of Suneetha B. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suneetha B. Thomas. Suneetha B. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hurt, Elaine M., Suneetha B. Thomas, Kathy Mulgrew, et al.. (2021). Abstract 1828: AZD8853: A novel antibody targeting GDF15 for immunotherapy refractory tumors. Cancer Research. 81(13_Supplement). 1828–1828. 2 indexed citations
2.
Dosch, Joseph S., Shanshan Wan, Kathryn E. Luker, et al.. (2017). Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget. 8(39). 65090–65099. 36 indexed citations
3.
Bao, Haifeng, Xiaoru Chen, Suneetha B. Thomas, et al.. (2016). Evaluation of anti-cancer stem cell activity of the anti-DLL4 antibody MEDI0639 in a phase I clinical trial of SCLC.. Journal of Clinical Oncology. 34(15_suppl). e20093–e20093. 2 indexed citations
4.
Cabarcas‐Petroski, Stephanie, et al.. (2013). The Differentiation of Pancreatic Tumor-Initiating Cells by Vitronectin Can Be Blocked by Cilengitide. Pancreas. 42(5). 861–870. 5 indexed citations
5.
Leow, Ching Ching, Ivan Inigo, Suneetha B. Thomas, et al.. (2013). Abstract A49: Anti-DLL4 antibodies inhibit cancer stem cells in small cell lung cancer.. Molecular Cancer Therapeutics. 12(11_Supplement). A49–A49. 1 indexed citations
6.
Cabarcas‐Petroski, Stephanie, Suneetha B. Thomas, Xiaohu Zhang, et al.. (2011). The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres. Genomics. 99(2). 108–117. 6 indexed citations
7.
Crea, Francesco, Maria A. Serrat, Elaine M. Hurt, et al.. (2010). BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. International Journal of Cancer. 128(8). 1946–1954. 71 indexed citations
8.
Klarmann, George J., Elaine M. Hurt, Lesley Mathews, et al.. (2009). Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clinical & Experimental Metastasis. 26(5). 433–446. 181 indexed citations
9.
Hurt, Elaine M., King C. Chan, Maria A. Serrat, et al.. (2009). Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation. Stem Cells. 28(3). 390–398. 64 indexed citations
10.
Hurt, Elaine M., Brian T. Kawasaki, George J. Klarmann, Suneetha B. Thomas, & William L. Farrar. (2008). CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer. 98(4). 756–765. 354 indexed citations
11.
Sharifi, Nima, Elaine M. Hurt, Suneetha B. Thomas, & William L. Farrar. (2008). Effects of Manganese Superoxide Dismutase Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer. Clinical Cancer Research. 14(19). 6073–6080. 40 indexed citations
12.
Hurt, Elaine M., Suneetha B. Thomas, Benjamin Peng, & William L. Farrar. (2007). Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. British Journal of Cancer. 97(8). 1116–1123. 63 indexed citations
13.
Hurt, Elaine M., Suneetha B. Thomas, Benjamin Peng, & William L. Farrar. (2006). Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator. Cancer Biology & Therapy. 5(9). 1154–1160. 31 indexed citations
14.
Peng, Benjamin, Elaine M. Hurt, David R. Hodge, Suneetha B. Thomas, & William L. Farrar. (2006). DNA Hypermethylation and Partial Gene Silencing of Human Thymine-DNA Glycosylase in Multiple Myeloma Cell Lines. Epigenetics. 1(3). 138–145. 35 indexed citations
15.
Hurt, Elaine M., Suneetha B. Thomas, Benjamin Peng, & William L. Farrar. (2006). Integrated molecular profiling of SOD2 expression in multiple myeloma. Blood. 109(9). 3953–3962. 44 indexed citations
16.
Hodge, David R., Benjamin Peng, Celine Pompéia, et al.. (2005). Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biology & Therapy. 4(5). 585–592. 47 indexed citations
17.
Peng, Benjamin, David R. Hodge, Suneetha B. Thomas, et al.. (2004). Epigenetic Silencing of the Human Nucleotide Excision Repair Gene, hHR23B, in Interleukin-6-responsive Multiple Myeloma KAS-6/1 Cells. Journal of Biological Chemistry. 280(6). 4182–4187. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026